Podiatrists in Rock Hill, SC Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Dr. Thomas Hunter Olson, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 724 Arden Lane, Suite 200, Rock Hill, SC 29732 Phone: 803-366-9440    Fax: 803-366-7704

Christopher H Crabtree, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 430 S Herlong Ave, Suite 105, Rock Hill, SC 29732 Phone: 803-327-2217    Fax: 803-327-2272

Palmetto Podiatry Group Of Anderson, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 430 S Herlong Ave, Suite 105, Rock Hill, SC 29732 Phone: 803-327-2217    Fax: 803-327-2272

Piedmont Podiatry Group Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 724 Arden Ln, Suite 200, Rock Hill, SC 29732 Phone: 803-366-9440    Fax: 803-366-7704

Instride Foot & Ankle Specialists, Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 223 Herlong Ave S Ste 115, Rock Hill, SC 29732 Phone: 803-327-1654    Fax: 803-283-9920

Catherine Ann Paukovitz, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 430 S Herlong Ave, Suite 105, Rock Hill, SC 29732 Phone: 803-327-2217    Fax: 803-327-2272

News Archive

Researchers uncover mechanism critical to keeping blood stem cells functional

Hematopoietic stem cells, that form mature blood cells, require a very precise amount of protein to function - and defective regulation of protein production is common in certain types of aggressive human blood cancers.

Faults in p53 gene could help predict beneficial drug combination for ovarian cancer

FAULTS in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology.

Damon Runyon holds fourth annual Accelerating Cancer Cures Research Symposium

Today, the Damon Runyon Cancer Research Foundation held the fourth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that the United States District Court for the District of Nevada denied Duramed Pharmaceuticals, Inc.'s request for a preliminary injunction and request for a temporary restraining order preventing Watson's launch of generic SEASONIQUE and ethinyl estradiol.

Read more Medical News

› Verified 9 days ago